Systemic hormonal preparations

Systemic hormone medications are prescribed for a wide range of medical conditions. Farmak International works as a hormone therapy distributor and a systemic hormone treatments supplier for healthcare providers.

Systemic Hormonal Therapeutic Portfolio

Our systemic hormonal solutions cover corticosteroids, thyroid hormone medications, peptide hormones, and selected endocrine support medicines. The systemic hormonal preparations line includes betamethasone suspensions for injection, dexamethasone solution for injection, hydrocortisone acetate suspension for injection, methylprednisolone tablets, levothyroxine sodium tablets, and desmopressin in nasal drops and spray. It also includes peptide hormones used in inpatient protocols, such as vasopressin, terlipressin, and octreotide injections, as well as carbetocin used in obstetric protocols.

These systemic hormone therapy drugs are reviewed the same way clinicians use them: by strength, primary pack, and substitution risk. For hormone injection pathways, pack identity matters as much as the milligram strength, and we keep these variables explicit. When a tender needs a glucocorticoid medication supplier for hospitals, we confirm the requirement scope early and align it to local status.

Clinical Applications and Treatment Indications

Farmak International’s systemic hormonal preparations are positioned for the two places hospitals feel the most pressure: long-term endocrine maintenance and short-notice inpatient escalation.

Pharmacy committees review endocrine lines by dossier readiness, pack stability, and distribution conditions. We are assessed as a thyroid hormone medications distributor for hospitals and are integrated into broader endocrine tenders that may also involve an insulin therapy products distributor.

Product Specifications & Formulations

On https://farmak.com/products/, each systemic item is presented with release form, strength, primary packaging, status, and dossier type. Oral systemic hormonal formulations are supplied in unit-controlled packs for routine dispensing; injectable hospital lines are supplied in ampoules, vials, or prefilled syringes for controlled storage. For systemic hormone therapy drugs, storage follows the locally approved label, and hormone injection logistics are planned around traceable handoffs and temperature control when the label requires it.

Quality Assurance & Regulatory Compliance

As a hormonal replacement therapy distributor, we demonstrate quality through audits and certifications, including oversight by national authorities and inspections associated with WHO prequalification where applicable, supported by ISO-based management standards such as ISO 9001 and ISO 13485. Corticosteroid drugs supplier B2B dossiers include full CTD packages supporting EU marketing authorizations aligned with EMA regulatory standards across Europe.

Farmak International also runs quality control across raw materials, finished medicines, and packaging materials, and we keep pharmacovigilance active after release. Our sterile manufacturing site in Spain holds an EU GMP certificate following inspection by AEMPS.

Partnership with Farmak for Systemic Hormonal Supply

We act as a systemic hormone treatment supplier for long-term agreements with predictable availability and market-specific tender documentation. Across Europe, hospitals work with us as a hormone therapy distributor, keeping procurement aligned to local labeling and patent constraints.

If your tender includes additional endocrine therapy product categories, we can align them with systemic hormonal preparations within the same procurement process. If procurement also includes a bioidentical hormone products distributor requirements, we separate it clearly from systemic steroid and thyroid lines before contracting.

Send Farmak International your target country and shortlist, and we will confirm lead times and delivery conditions for your procurement pathway.